SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Neurobiological Tech (NTII)
NTII 0.00010000.0%Jan 9 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Dr. John M. de Castro who wrote (543)5/18/1999 10:26:00 AM
From: Apache Indian  Read Replies (1) of 1494
 
and then what are the chance of that English translating into the stock price ? If I remember correctly the only patent protection available for memantine are use patents since the matter patent has expired. So does this benefit NTII in any way ?? I dont know.

anyways all I care is $$, aka stock price. I noticed the increased volume, liquidity, and decreased spread like Chris said we would.
Thank god for that Nanocaps and Cohen.

Hope this leads NTII to a higher playing field, so that on the next news we hit the grand slam. I'm hoping for a buyout anyways, since I dont know if any royalty payments and marketing agreements would translate into a sustained rally in the share prices as opposed to the 2 hour pops that we get every six months. good luck everyone.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext